Interaction of Mandarin Oil with Nicorandil in Doxorubicin Induced Myocardial Infarction Introduction
Herbal medicines have become a popular in healthcare system. All herbal medicines are mixtures of more than one active ingredient. In many cases it is unknown that, which or how many constituents are pharmacologically active. Herbal medicines co-administered along with prescribed drug tend to have chronic conditions, which increases the risk of herb-drug interaction. [1] Interactions between herbs and drugs may increase or decrease the pharmacological and toxicological effects of either components. Synergistic therapeutic effects may complicate the dosing of long-term medications. [2] It has been stated that 15-20% of individuals uses herbal medicines along with their prescribed medications and less than 40% of patients disclose this to their physicians. The problem is further complexed by physicians those who are not aware with the potential of herb-drug interactions. Hence it is important to promote research on the safety and efficacy of herb-drug interaction for variety of diseases including cardiovascular diseases. [3] Nicorandil is a nicotinamide nitrate ester which is being increasingly used as the first-line and sole treatment in both stable and unstable angina and also drug approved for the treatment of ischaemic heart disease. It is believed to have dual properties of action, firstly, intrinsic mechanism of the drug i.e. selective activation of K + ATP channels at the sarcolemma and mitochondrial level. Secondly, because of K + ATP channels in ischaemic preconditioning, nicorandil has been attributed cardioprotective effects. [4] Mandarin oil, which is obtained from peel of Citrus reticulate Balnco [5] also called as Citrus aurantium L. which belong to family Rutaceae. [6] Mandarin oil has proved effective in treating cancer [7] , hypoglycaemia [8] , also used as antiangiogenic [9] and antifungal [10] which states that mandarin oil has a potent antioxidant property. [11] However, there are no scientific report to indicate the biochemical alterations, antioxidant profile, ECG parameters, hemodynamic findings and histological changes upon concomitant administration of mandarin oil along with nicorandil in DOX induced myocardial infarction. Hence, the present study was undertaken to evaluate the pharmacokinetic and pharmacodynamic interactions of nicorandil with mandarin oil in rats.
II. Methodology 2.1 Chemicals and Reagents:
All reagents and chemicals used in this study were of analytical grade. The enzyme kits were obtained from Erba Diagnostic Manheim GmbH, Germany and Crest Biosystem, Goa. Nicorandil was obtained from local pharmacy shop while mandarin oil was obtained from local supplier (Venkateshwar supplier, Bangalore). Plasma drug concentration was measured using HPLC (Shimadzu, Serial No. L12561) and all the reagents and chemicals used were of HPLC grade.
Experimental Animals:
Male wistar rats (150-200g) were housed at 25 ± 5 o C in a well-ventilated animal house under 12:12h light & dark cycle. The rats had free access to standard rat chow (Amrut Laboratory Animal Feed, Maharashtra, India) and water ad libitum. The institutional animal ethics committee approval was taken and animals were maintained under standard conditions.
Experimental design:
Male Wistar rats weighing 150 -200 g were used. The rats were grouped randomly into seven group of six each; Nicorandil will be administered i.p. at a dose of 3 mg/kg for 7 days [13] and Mandarin oil will be administered at a dose of 200mg/kg and 400mg/kg. [14] Group 1: received Normal saline. Group 2: serve as disease control group received DOX (10mg/kg, i.p.) for 2 days. Blood was withdrawn by retro-orbital puncture, serum was separated for biochemical estimation and animals were sacrificed after 48 hr. of DOX administration.
Pharmacokinetic Study:
Rats were treated with nicorandil (3mg/kg) alone and in combination with mandarin oil at a dose of 200mg/kg and 400mg/kg. Blood samples were collected from retro-orbital vein puncture using heparinised capillary tubes at 30, 60 and 120 mins. Plasma was separated after centrifugation at 8000 rpm for 15 min and stored at -20 °C.
Chromatographic Condition:
The mobile phase consisted of degassed (premixed) solution containing Methanol: Water (60:40, v/v). The mobile phase was filtered through a 0.22μm-sized membrane (micropore, USA) with flow rate of 0.6mL/min. Peak areas were determined with a spinchrome integrator. Metronidazole was adopted as an internal standard. Primary standard solutions of nicorandil and metronidazole (100µg/mL) was prepared in methanol. To each plasma containing tubes, 1 mL of metronidazole stock solution was added. Then aliquots of 100μL of plasma samples were taken and mixed with 250μL of acetonitrile and mixtures were vortexed for 30 seconds and centrifuged at 3000rpm for 10 minutes. A portion of supernatants were transferred to eppendorff tubes and 20μL was injected. The eluent was detected by the UV detector at 254nm. Under the described conditions, the retention time and peak area of nicorandil and metronidazole, was noted down and Time vs. Plasma drug concentration graph was plotted.
Concentration of Sample was found out using below equation: Concentration = X X X % Pu X % Purity of the drug
Histopathological Evaluation:
A portion of the heart was fixed in formalin (10%) and subjected to histopathological studies. The section of heart was processed and embedded in paraffin wax. Sections of about 4-6µm were made and stained with hematoxylin and eosin at 100x and photographed. 
Statistical Analysis
Results are expressed as mean ± SEM. The statistical significance was determined using one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test.
III.
Results 3.1 Pharmacodynamics parameters: 3.1.1 Cardiac marker enzyme of serum and heart tissue homogenate i.e. ALT, AST, LDH and CK-MB:
There was substantial fall (p<0.001) in activity of marker enzymes in heart tissue homogenate and rise (p<0.001) in the activities of marker enzymes in serum respectively upon DOX administration. Pre-treatment with nicorandil and mandarin oil alone significantly restored the activity to normal level in both heart homogenate and serum. But when combination was compared to nicorandil alone less significant restoration of marker enzymes was observed. (Graph no. 1 and Graph no. 2). 
Serum lipid Profile i.e. Total Cholesterol (T-CHO), TG, LDL, VLDL and HDL:
Cardiotoxic rats pre-treated with nicorandil and mandarin oil alone and in combination showed significant reduction (p<0.001) in T-CHO when compared with DOX induced rats. There was no significant difference in TG level observed when nicorandil and mandarin oil was given alone, but administration of nicorandil and mandarin oil in combination showed significant increase (p<0.001) in TG level when compared with DOX induced rats. Significant decrease in HDL and increase (p<0.001) in LDL and VLDL was observed in DOX treated when compared to normal group and pre-treatment with nicorandil and mandarin oil alone and in combination showed significant increase in HDL and restored LDL and VLDL level when compared to DOX induced rats. (Graph no. 3)
Graph No. 3: Effect of various treatments on Lipid Profile

Antioxidants i.e. GSH, SOD and MDA:
Significant decline in the activities of endogenous antioxidant enzymes was observed in the heart tissues of DOX treated rats. Pre-treatment with mandarin oil and combination with nicorandil offered significant protection (p<0.001) against DOX induced oxidative stress in terms of preservation of endogenous antioxidants but nicorandil alone showed less significant increase in antioxidant enzyme level when compared with DOX induced rats. The increased MDA level in DOX treated group is attribute to increase in lipid peroxidation associated tissue damage. Pre-treatment with nicorandil and mandarin oil alone and in combination appeared to have a protective effect on lipid peroxidation by decreasing (p<0.001) MDA level in heart tissue homogenate. (Table no 
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All values are expressed as mean ± SEM for six animals in each group using one-way analysis of variance 
Body weight, ECG and Heart Rate:
Present study showed that, DOX caused significant decrease in body weight. The rats pre-treated with nicorandil and mandarin oil alone and in combination showed significant increase in body weight. ECG alterations were monitored, DOX treated group showed significant prolongation of QT interval and elevation of ST segment, with significant increase in heart rate. Pre-treatment with nicorandil alone significantly reduced ECG alterations. But, concomitant pre-treatment with mandarin oil alone and in combination with nicorandil significantly decreased the alterations in cardiotoxic rats. (Table no 
Pharmacokinetic Determination:
As depicted from plasma drug concentration vs. Time graph (Graph no. 4), time required to reach peak (T max ) plasma concentration of nicorandil alone occurred at 30 min while in combination with mandarin oil, occurred at 60 mins, whereas C max of nicorandil alone was 324.3µg while nicorandil in presence of mandarin oil at dose of 200mg/kg is 196.4µg and at 400 mg/kg is 240.5µg. Therefore substantially decrease in C max and increased T max indicating decreased extent of absorption of nicorandil in presence of mandarin oil. 
Histopathological Evaluation:
Myocardial integrity was disturbed by administration of DOX i.p for 2 consecutive days showed degenerative changes like necrosis, vascular edema etc. Pre-treatment with nicorandil and mandarin oil alone and there combination restored normal myofibril condition. (Fig no. 1) A 
IV. Discussion
The aim of the present study was to explore interaction of mandarin oil with nicorandil in DOX induced myocardial infarction. Results revealed the presence of pharmacodynamic and pharmacokinetic interaction when mandarin oil was administered in combination with nicorandil in cardiotoxic rats. DOX, an anthracycline antibiotic, widely used as anticancer agent. It has been believed that DOX induced cardiac injury, mainly mediated through free radical generation; iron-dependent oxidative damage to the biological macromolecules and membrane lipid peroxidation. [15] DOX administered rats showed ECG change, free radical generation, antioxidant deficit, and increase levels of serum lipid profile, significant decrease in the activities of cardiac marker enzymes, cardiomyopathy and eventually congestive heart failure. [16] DOX induced myocardial damage associated with decrease in endogenous antioxidants such as superoxide dismutase (SOD), GSH and MDA that are structurally and functionally impaired by free radicals resulting in damage to myocardium [17] . Elevated activity of GSH, SOD and MDA was found to be significant increase with pre-treatment of mandarin oil alone and in combination with nicorandil provides integrity of myocardium. Administration of DOX leads to damage of myocardial tissue which causes the release of marker enzymes in blood stream and depletion in myocardial tissue. This condition was pre-dominantly restored by alone treatment of nicorandil and mandarin oil. Pre-treatment with nicorandil and mandarin oil alone and in combination significantly restored lipid level and also increased HDL level.
Damage to cardiac muscle was also demonstrated and confirmed by histopathology. Nicorandil and mandarin oil alone and in combination were found to minimise the damage induced by DOX. The electrocardiographic parameters were normalized in individual therapy especially heart rate was reverted to normal conditions as well as QRS duration was reduced indicating protection from myocardial ischemia. Present study showed that individual treatment is more effective in cardioprotection and combinational treatment due to presence of pharmacodynamic interaction in mandarin oil and nicorandil. Pharmacokinetically mandarin oil was interacting with nicorandil, as observed in Plasma drug concentration vs. Time, plot, showed decrease in C max and increase T max .
V. Conclusion
In conclusion, it can be interpreted that mandarin oil and nicorandil should be avoided in combination because of presence of pharmacodynamic and pharmacokinetic interaction, which was observed in treatment of myocardial infarction induced by DOX. Hence, further studies can be carried out to determine the influence of specific active constituent responsible for interaction of mandarin oil with nicorandil in myocardial damage. This type of study will open new areas and will be helpful in carrying out further research of interaction between herb and conventional drugs when they are taken concurrently.
